Strategic Clinical Consultants

Realities of Precision Medicine

Monday, February 15, 2016

As biopharmaceutical companies in­crease R&D investment in precision medicine, a trend that is expected to rise by one-third in the next five years, clini­cal research professionals will need to imple­ment operating practices and processes that can meet the complex demands of an indi­vidualized approach to drug development.

[Read More]